Sharon Henderson

A new packaging innovation offers a path to sustainability without the operational headaches, signaling a systemic shift in how we handle e-commerce waste.

iPower Inc. secured $2M to fund a pivot into AI, but a closer look reveals a company battling financial headwinds while making a risky bet on its future.

After a Health Canada-mandated pause, LSL's Steri-Med is near full remediation. This is more than a fix—it’s a calculated play for North American market leadership.

Philips Evnia's new monitor isn't just hardware; it's a strategic play to end the gamer's dilemma. Can one screen truly master both speed and spectacle?

Sandisk's latest 3D NAND memory isn't just a tech upgrade. It's a strategic move in the high-stakes battle to power the AI revolution. Here's why.

Roc Nation and Paramount+ aren't just streaming a historic concert. They are testing the future of national celebrations and redefining the flow of cultural power.

Xeltis's bioabsorbable aXess graft hits a major US trial milestone, signaling a strategic shift in renal care away from failing synthetics to living tissue.

Molecular Partners and Orano Med begin human trials for a novel radiopharmaceutical, hoping to unlock a new front against small cell lung cancer.

The Hawaiian Native Corporation's defense contracting arm, formerly DAWSON, is now LAUKOA. It's more than a new logo; it's a calculated move in a high-stakes game.

Dallas's Carter Arnett rebrands, elevating two elite women litigators. It's more than a name change—it's a strategic play for dominance in high-stakes law.

As AI agents proliferate, they remain isolated. Fulcra Dynamics' new infrastructure gives them a shared, secure memory, a crucial step toward true AI collaboration.

The National Kidney Foundation's new chief brings a personal mission and a history of strategic innovation to confront a silent, multi-billion-dollar crisis.

Vyome Holdings secures a key patent in China, not by betting the farm, but by making a shrewd, capital-efficient move to tap into a massive future market.

The commodities giant's move from London to Bermuda is more than a change of address. It's a strategic play to simplify, cut costs, and align with US markets.

Ecovyst's quiet acquisition of Calabrian is more than a line item. It's a calculated pivot from a niche acid supplier to a diversified sulfur chemistry powerhouse.

As Frost & Sullivan names Securden a PAM leader, a closer look reveals a strategic shift from complex, acquired tech to unified, native platforms.

A new partnership between healthcare giant Henry Schein and tech platform GoTu isn't just about filling jobs—it's a strategic power play to solve a systemic crisis.

iCIMS's latest Gartner Leader status isn't just an accolade. It reveals a deep strategic push to own the enterprise talent market with responsible AI.

Healthcare titan Steve Wiggins, who built and sold empires in managed care, is making his next play. His advisory role at OMI is a major bet on specialty care tech.

As aid lands in earthquake-ravaged Venezuela, it meets a crisis years in the making. A look at the fragile lifeline and the monumental task ahead.